High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis

Digestive Diseases and Sciences

Volumn 48, Issue 6, 2003, Pages 1186-1192

  Bene, László ^a   Füst, George ^b,c   Fekete, Béla ^b   Kovács, Ágota ^a   Horváth, Laura ^b   Prohászka, Zoltán ^b,c   Miklós, Kata ^d   Pálos, Gábor ^b   Daha, Mohamed ^e   Farkas, Henriette ^b   Varga, Lilian ^b,d  

^a Peterfy Hospital   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d NATIONAL MEDICAL CENTER   (Hungary)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C reactive protein; Complement; Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; ARTICLE; BLOOD LEVEL; COMPLEMENT SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C3; COMPLEMENT C4; CROHN DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE;

EID: 0037865427     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023793502456     Document Type: Article

References (32)

1. Nielsen OH, Vainer B, Madsen SB, Seidelin SB, Heegard NHH: Established and remerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 95:359-365, 2000
2. Sandborn WJ, Loftus EV, Colombel JF, Fleming KA, Seibold F, Homburger HA, Sendid B, Chapman RW, Tremaine WJ, Kaul DK, Wallace J, Harmsen WS, Zinsmelster AR, Targan SR: Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflam. Bowel Dis 7:192-201, 2001
3. Wedel S, Scriber S: Laboratory tests in inflammatory bowel disease. In Inflammatory Bowel Diseases - from Bench to Bedside. T Andus, H Goebbel, P Layer, J Schölmerich (eds). Kluwer Academic, Dordrecht, The Netherlands, 1997, pp 235-241.
4. Nielsen H, Wiik A, Elmgreen JE: Granulocyte-specific antinuclear antibodies in ulcerative colitis APMIS 91:23-26, 1983
5. Main J, Mc Kenzie H, Yeaman GR, Kerr MA: Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease. Br Med J. 297:1105-1106, 1988
6. Maeda M, Watanabe N, Neda H, Yamauchi N, Okamoto T, Sasaki H, Tsuji Y, Akiyama S, Tsuji N, Niitsu Y: Serum tumor necrosis factor activity in inflammatory bowel disease. Immunotoxicology 14:451-461, 1992
7. Cassini-Raggi V, Kam L, Chong YJT, Fiocchi G, Pizzaro TT, Comiaelli F: Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J Immunol 154:2434-2340, 1995
8. Mahida YR, Kurlac C, Galagher A, Hawkey CJ: High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 32-1531-1534, 1992
9. Nielsen OH, Langholz E, Hendel J, Brynskov J.: Circulating soluble intercellular adhasion molecule- (sICAM-1) in inflammatory bowel disease. Dig Dis Sci 39:1918-1923, 1994
10. Patel PH, Pall AA, Adu D, Keighley MR: Circulating soluble adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 7:1037-1041, 1995
11. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D: Anti-Saccharomyces cerevisae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42:788-791, 1998
12. Ruemmele FH, Targan SR, Levy G, Dubiaski M, Braun J, Seidman EG: Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 115:822-829, 1998
13. Kirschfink M: The clinical laboratory: testing the complement system. In The Complement System K Rother, GO Till and G Hansch (eds). Springer Verlag, Berlin, 1998, pp. 522-540
14. Amelio RD, Rossi P, Moli SLE, Ricci R, Montano S, Pallone F: In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique Gut 22:566-570, 1981
15. Elmgreen J, Berkowicz A, Soensen H: Defective release of C5a related chemo-attractant activity from complement in Crohn's disease. Gut 24:525-531, 1983
16. Lake AM, Stitzel AE, Urmson JR, Walker WA, Spitzer RE: Complement alterations in inflammatory bowel disease Gastroentraology 76:374-379, 1979
17. Elmgreen J, Both H, Binder V: Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatbolism of complement. Gut 26:151-157, 1985
18. Hodgson HJF, Potter BJ, Jewell JP: C3 metabolism in ulcerative colitis and Crohn's disease. Clin exp Immunol 28:490-495, 1977
19. Elmgreen J, Berkowitz A, Sorensen H: Hyper catabolism of complement in Crohn's disease. Acta Med Scand 214:403-407, 1983
20. Ahrenstedt Ö, Knutson L, Nilsson B, Nilsson-Ekdahl K, Odlind B, Hallhren R: Enhanced local production of complement components in small intestines of patients with Crohn's disease. N Engl J Med 322:1345-1349, 1990
21. Laufer J, Oren R, Goldberg I, Horwitz A, Koplovic J, Chowers Y, Passwell JH: Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease. Clin Exp Immunol 120:30-37, 2000
22. Haltensten TS, Mollnes TE, Garred P, Fausa O, Brandtzaeg P: Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis. Gut 33:902-908, 1992
23. Ueki T, Mizumo M, Uesu T, Kiso T, Nasu J, Inaba T, Kihara Y, Matsuoka Y, Okada H, Fujita T, Tsuji T: Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC) Clin Exp Immunol 104:286-292, 1996
24. Hodgson HJF, Potter BJ, Jewell DP: Humoral immune response in inflammatory bowel disease I. Complement levels Gut 18:749-753, 1977
25. Walport MJ: Complement and systemic lupus erythematosus. Arthritis Res 4:S279-S293, 2002
26. Best WR, Becktel IM, Singleton J, Kern F Jr: Development of Crohn's disease activity index. Gasroenterology 70:439-444, 1976
27. Truelove SC, Witts LJ: Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 2:1041-1048, 1955
28. Kohler PF, Müller-Eberhard HJ: Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations of sera in healthy adults. J Immunol 99:1211-1216, 1967
29. Siegert, CEH, Daha MR, van der Voort EAM, Breedvelt FC: IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis. Arthritis Rheum. 33:1646-1654, 1990
30. Halstensen TS, Mollnes TE, Fausa O, Brandtzaeg P: Depositts of terminal complement complex (TCC) in muscular mucosae and sub-mucosal vessels in ulcerative colitis and Crohn's disease of the colon. Gut 30:361-366, 1989
31. Halstensen TS, Mollnes TE, Brandtzaeg P: Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: Immunochemical evidence. Gastroenterology 97:10-19, 1989
32. Halstensen TS, Mollnes TE, Garred P, Fausa O, Brandtzaeg P: Epithelial deposition of immunoglobulin G and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology 98:1264-1271, 1990